White Paper

How Sponsors And CROs Benefit From EDC Efficiencies

Source: IBM Clinical Development
How Sponsors And CROs Benefit From EDC Efficiencies

The question used to be a relatively simple one: how can a pharmaceutical company conduct efficient and effective trials? As the industry has changed over the past decade, pharmaceutical companies need the ability to access study information in real time so they can make better decisions regarding the viability of a compound as soon as possible in the study process. In no uncertain terms, time equals money in this industry.

Given the changing face of clinical trials, there is a unique opportunity for clinical research organizations (CROs) and Electronic Data Collection (EDC) vendors to join forces to better serve the pharmaceutical industry. With the goal of helping sponsors bring new and more efficacious drugs safely to market, CROs have much to gain from using advanced EDC platforms. The benefit to implementing EDC is that it provides an expedited clinical trial process through efficient study design and deployment as well as access to real-time data. And when the right EDC platform is selected, the control of the study is placed firmly in the hands of the sponsors and CROs